Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Praxis Precision Medicines announced positive mid-cycle FDA meetings for its drug candidates ulixacaltamide and relutrigine, with no major safety or efficacy concerns and no advisory committee meetings planned. The company is accelerating commercial preparations for potential approvals in essential tremor and developmental epileptic encephalopathie…
ASP Isotopes Inc. announced that its subsidiary Renergen's subsidiary, Tetra4, has entered a five-year take-or-pay contract to supply liquified natural gas (LNG) to a South African food processor. This contract supports Phase 1 of the Virginia Gas Project, targeting commercial production in Q3 2026, with approximately 75% of Phase 1 LNG volumes now…
Annexon, Inc. reported early positive clinical responses from the initial cohort of U.S. and European Guillain-Barré syndrome (GBS) patients treated with tanruprubart in its ongoing FORWARD study. All ten patients demonstrated rapid and meaningful improvement in strength and functionality within days, reinforcing earlier Phase 3 trial results and s…
Madrigal Pharmaceuticals announced its participation in the Canaccord Genuity 46th Annual Growth Conference where it will present its latest developments. The company focuses on developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), with its drug Rezdiffra already approved in the US and Europe for treating MASH with mo…
Pacira BioSciences announced positive two-year Phase 1 clinical trial results for PCRX-201, its investigational gene therapy for moderate-to-severe knee osteoarthritis. The therapy showed a strong safety profile and sustained improvements in pain, stiffness, and function following a single intra-articular injection. With these encouraging results, …
MNTN looks set to trade higher as operating cash flow catches up with earnings and the company's net-cash balance sheet separates enterprise value from headline market cap. Premium multiples still price growth, but a clear path to stronger free cash generation and several near-term catalysts create a pragmatic trade: enter at $10.30, target $14.00,…
Acorn Energy announced its Q2 2026 results, highlighting a 29% revenue decline primarily due to lower hardware sales from a major cell phone provider contract. However, high-margin recurring monitoring revenue grew 8% and gross margins improved significantly. Growth initiatives include a strategic partnership with Champion Power Equipment for resid…
ConocoPhillips completed a $1.7 billion sale of noncore Lower 48 assets in July, allowing the company to achieve its $5 billion divestiture target earlier than planned. The transaction was disclosed alongside second-quarter results that showed better-than-expected profit, and coincided with the announcement that CEO Ryan Lance will retire and CFO A…
Datadog shares tumbled roughly 21% in premarket trading to around $223 despite a quarter that beat expectations across revenue and earnings and lifted full-year guidance. The company reported $1.12 billion in revenue, up 36% year-over-year, and raised its revenue and EPS targets for the year. Investors appear to be reacting to a long run-up into th…
Keurig Dr Pepper shares rose about 1% in pre-market trading after the company reported adjusted earnings of $0.57 per share and net sales of $7.31 billion for the second quarter, both ahead of consensus. The results reflect substantial year-over-year revenue growth driven in part by the April 2026 closing of the $18 billion JDE Peet’s acquisition. …
SanDisk plunged about 10% in pre-market trading to roughly $1,215 after reporting a solid Q4 and high gross-margin guidance but setting Q1 revenue guidance slightly below Street consensus. The quarter delivered revenue of $8.97 billion, a 372% year-over-year increase, and gross margin guidance of 83-85%, yet the market reacted to the small revenue …
MACOM Technology Solutions rallied in early trading after reporting fiscal third-quarter 2026 results that beat analyst expectations. Adjusted EPS of $1.40 topped the consensus of roughly $1.35, and adjusted gross margin expanded to 59.7% from both the prior quarter and the year-ago period. The move occurred against a flat broader market, driven by…
Universal Technical Institute (UTI) saw its stock slide 14.2% in pre-market trading after releasing fiscal third-quarter 2026 results and narrowing its baseline adjusted EBITDA outlook. While earnings per share and enrollment measures beat or showed healthy momentum, a revenue shortfall and management’s attribution of most of the guidance reduction…
Six publicly traded companies saw steep premarket declines after reporting quarterly results and issuing guidance, with share moves ranging from -9.0% to -22.9%. The selloffs reflected a mix of forward guidance reductions, revenue or EPS misses, execution shortfalls, and valuation resets following strong prior rallies. Each company faced a distinct…
argenx announced a cash tender offer to acquire all outstanding shares of Forte Biosciences at $77 per share. Upon acceptance, Forte will merge as a wholly owned subsidiary of argenx, aiming to expand argenx's immunology portfolio with Forte's clinical-stage anti-CD122 monoclonal antibody candidate. This strategic acquisition is expected to strengt…
Geo Group Inc. shares rose about 2.6% in pre-open trading after the company reported second-quarter 2026 results that exceeded analyst forecasts on both earnings and revenue, posted a double-digit adjusted EBITDA gain year-over-year, and boosted full-year guidance. Growth tied to expanded federal immigration detention contracts - including a five-y…
Arhaus Inc. shares climbed nearly 7.0% in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations on both revenue and adjusted earnings. The beat was driven in part by $23.8 million in IEEPA tariff recoveries, lifting gross margin and supporting cash flow after the company said it had received th…
Celestica shares dropped 15% after the company announced a $3 billion common share offering priced at $310 per share, a significant discount to the previous closing price of $362.76. The deal includes an underwriter option for additional shares and is expected to close on or about August 7, 2026, subject to customary closing conditions and exchange…
Kenvue reported second-quarter adjusted earnings and revenue that narrowly missed analyst expectations as inflation, tariffs and currency-related costs compressed gross margins. Sales grew modestly across the company's divisions, while management signaled a 2026 restructuring charge and reiterated expectations for the Kimberly-Clark takeover to clo…
Six Flags Entertainment reported second-quarter 2026 results that fell short of Wall Street revenue expectations and showed a wider net loss, pushing shares lower in pre-market trading. While same-park revenue and visitation rose modestly, the sale of seven parks and weaker per-capita spending diluted headline results and left adjusted EBITDA rough…
Kenvue opened lower in pre-market trading after reporting second-quarter 2026 results that missed analyst expectations on both revenue and adjusted earnings per share. The company posted adjusted EPS of $0.31 on $3.96 billion in revenue, while net sales and organic sales showed year-over-year growth. Market uncertainty was amplified by the absence …
MPLX reported a quarter that felt soft at face value, but underlying cash generation, an intact distribution and modest deleveraging mean the business risk just dropped. The stock trades at roughly $60, yields ~7.1%, and carries tangible upside if volumes and project execution remain steady. This trade idea lays out an entry at $59.50, a stop at $5…
D-Wave Quantum shares plunged in pre-market trading after the company reported second-quarter results that missed Wall Street revenue and loss-per-share estimates. Quarterly revenue of $3.07 million and a loss of $0.13 per share both came in worse than consensus, undercutting optimism fueled by recent research, a new commercial agreement and an ana…
Unity Software shares climbed sharply in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations on both revenue and adjusted profitability, and issued third-quarter revenue guidance slightly above consensus. Strength in the company's AI-driven Vector platform and its Grow segment have underpinne…
Molson Coors Brewing Co Class B shares rose about 1.3% in pre-market trading to $42.42 after the company released second-quarter 2026 results that modestly exceeded analyst projections for adjusted EPS and revenue. Adjusted EPS was $1.58 versus a consensus near $1.52, and revenue was $3.10 billion versus a $3.09 billion estimate. Adjusted EBITDA ca…
